Acute Lymphoblastic Leukemia, Pediatric Not Yet Recruiting Phase 2 Trials for Doxorubicin (DB00997)

Also known as: Pediatric Acute Lymphoblastic Leukemia / Acute Lymphoblastic Leukemia in Pediatric / Pediatric Patients With Acute Lymphoblastic Leukemia / Leukemia, Lymphoblastic, Acute, Pediatric

IndicationStatusPhase
DBCOND0081765 (Acute Lymphoblastic Leukemia, Pediatric)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT06184009Treatment of Newly Diagnosed High Risk Pediatric Acute Lymphoblastic LeukemiaTreatment